GlycoMimetics to Present at Two Investor Conferences in March
-
President & CEO
Rachel King will present at theCowen & Co. 35th Annual Healthcare Conference,The Boston Marriott Copley Place ,Boston , onMarch 2, 2015 , at2:10 p.m. ET . The company will also participate in a breakout session at2:50 p.m. ET that day. -
Ms. King will participate in a plenary session panel at the Bio-Europe Spring® 2015 Conference,Paris, France , onMarch 9, 2015 , at10:45 a.m. DT.
To access the live webcast and subsequent archived recordings for the presentation at the Cowen conference, please visit the GlycoMimetics website at www.glycomimetics.com.
About
GlycoMimetics is a clinical stage biotechnology company focused on the
discovery and development of novel glycomimetic drugs to address unmet
medical needs resulting from diseases in which carbohydrate biology
plays a key role.
bhahn@glycomimetics.com
Source:
News Provided by Acquire Media